Key result
Expression of hsa_circ_0105015 was significantly higher in essential hypertension patients (P=0.002), and its combination with hsa-miR-637 yielded an area under the curve of 0.703 (P<0.001).
Why the study?
Endothelial dysfunction induced by chronic inflammation contributes to essential hypertension pathogenesis, and inflammatory mediators may be regulated by interactions between circRNAs and miRNAs.
Case-Control (n=96)
Effect estimate: AUC 0.703
p-value: p=<.001
Hyperexpression of hsa_circ_0105015 combined with hypoexpression of hsa-miR-637 may serve as a potential biomarker for early diagnosis of essential hypertension and vascular inflammation.
Clinical meaning/caution now):* Identifies a potential novel biomarker profile for essential.
BACKGROUND: Essential hypertension (EH) is an inflammatory disease, and endothelial dysfunction induced by chronic inflammation is one of the pathogeneses of EH. The expression of some inflammatory mediators may be regulated by the interaction of circular RNAs (circRNAs) and microRNAs (miRNAs). METHODS: An Agilent human circRNA microarray was used to identify the expression profile of circRNAs in EH. qRT-PCR was used to evaluate the relative expression of circRNAs in 48 pairs of human whole blood samples (sex and age ± 3 years matched) and endothelial cells. TNF-α was applied to induce endothelial cells inflammation. CircRNA-miRNA network was predicted by MiRanda software. RESULTS: There were 287 circRNAs differentially expressed in the microarray. The top 10 up-regulated circRNAs in the EH group were hsa_circ_0014243, hsa_circ_0133228, hsa-circRNA14116-3, hsa_circ_0079536, hsa-circRNA13649-1, hsa_circ_0117886, hsa_circ_0007075, hsa-circRNA15285-1, hsa-circRNA10088-9, and hsa-circRNA14119-10; the top 10 down-regulated circRNAs were hsa_circ_0100094, hsa_circ_0127342, hsa_circ_0093773, hsa_circ_0096334, hsa_circ_0131618, hsa_circ_0063886, hsa_circ_0097804, hsa_circ_0126640, hsa-circRNA8935-1, and hsa_circ_0039978 (fold change in descending order). Hsa_circ_0105015 has two predicted binding sites with hsa-miR-637. The relative expression of hsa_circ_0105015 in EH patients was significantly higher than healthy controls (P = .002), and similar results appeared in TNF-α-induced endothelial cells. The area under the curve after hsa_circ_0105015 combined with hsa-miR-637 was 0.703, P < .001. CONCLUSION: Hyperexpression of hsa_circ_0105015 is a significant risk factor of EH and its association with EH involves inflammatory pathways. Hyperexpression of hsa_circ_0105015 combined with hypoexpression of hsa-miR-637 indicates vascular inflammation or endothelial dysfunction and has potential as a biomarker for early diagnosis of EH.
No takes yet. Share an insight, caveat, or question.
He et al. (2020) conducted a case-control in Essential hypertension (n=96). hsa_circ_0105015 expression vs. Healthy controls was evaluated on Diagnostic value of hsa_circ_0105015 combined with hsa-miR-637 (AUC 0.703, p=<.001). Expression of hsa_circ_0105015 was significantly higher in essential hypertension patients (P=0.002), and its combination with hsa-miR-637 yielded an area under the curve of 0.703 (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: